Company Information for CHIROTECH TECHNOLOGY LIMITED
C/O Kingsbridge Corporate Solutions, 1st Floor Lowgate House, Lowgate, Hull, HU1 1EL,
|
Company Registration Number
![]() Private Limited Company
Liquidation |
Company Name | |
---|---|
CHIROTECH TECHNOLOGY LIMITED | |
Legal Registered Office | |
C/O Kingsbridge Corporate Solutions, 1st Floor Lowgate House Lowgate Hull HU1 1EL Other companies in CB4 | |
Company Number | 02667953 | |
---|---|---|
Company ID Number | 02667953 | |
Date formed | 1991-12-03 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Liquidation | |
Lastest accounts | 2020-03-31 | |
Account next due | 31/12/2021 | |
Latest return | 2019-11-25 | |
Return next due | 31/12/2016 | |
Type of accounts | FULL | |
VAT Number /Sales tax ID |
Last Datalog update: | 2024-09-18 11:52:48 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Registered address | Last known status | Formation date | ||
---|---|---|---|---|
CHIROTECH TECHNOLOGY LIMITED | Unknown |
Officer | Role | Date Appointed |
---|---|---|
PAKALA CHAKRAPANI |
||
DAVID ANDREW CHAPLIN |
||
SUBIR KOHLI |
||
VENKATA NARSIMHAM MANNAM |
||
GUNAPATHI VENKATESHWARA PRASAD |
||
KALLAM SATISH REDDY |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
ABBAS BANDALI |
Company Secretary | ||
RAGHUNATHAN ANANTHANARAYANAN |
Director | ||
SRINIVAS DRONAMRAJU |
Company Secretary | ||
JONATHAN PAUL KILHAM |
Director | ||
SAMEER NATU |
Company Secretary | ||
ABHIJIT MUKHERJEE |
Director | ||
IONA LORRAINE DANCE |
Company Secretary | ||
GEOFFREY COLIN FINKEMEYER |
Director | ||
GEOFFREY WILLIAM DANN |
Director | ||
ASCOT CORPORATE DIRECTORS LIMIYED |
Director | ||
ASCOT CORPORATE SECRETARIES LIMITED |
Company Secretary | ||
MICHAEL EVANS |
Director | ||
JOHN NIGEL EDWARDS |
Director | ||
RICHARD JOHN MEYERS |
Director | ||
JOHN BENEDICT ALAN WILLIAMS |
Company Secretary | ||
MARK ROY MASON JENNER |
Company Secretary | ||
ANTHONY JOHN GILLHAM |
Director | ||
CHRISTINE HELEN SODEN |
Company Secretary | ||
BRIAN ALBERT GENNERY |
Director | ||
ROBERT CHARLES JACKSON |
Director | ||
JONATHAN PHILIP DICKENS |
Director | ||
BRIAN ADGER |
Director | ||
CHRISTOPHER THOMAS EVANS |
Director | ||
ARTHUR JAMES HALE |
Director | ||
PETER STEPHEN KEEN |
Company Secretary | ||
WILLIAM ALEXANDER MCINTOSH DUNCAN |
Director | ||
PETER STEPHEN KEEN |
Director | ||
WILLIAM EDGE |
Director | ||
PETER MCPARTLAND |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
DR REDDY'S LABORATORIES (UK) LIMITED | Director | 2018-02-20 | CURRENT | 1983-06-03 | Active | |
DR. REDDY'S LABORATORIES (EU) LIMITED | Director | 2013-04-10 | CURRENT | 1987-10-13 | Active | |
SATYAM BPO LIMITED | Director | 2003-10-30 | CURRENT | 2003-10-08 | Active |
Date | Document Type | Document Description |
---|---|---|
Final Gazette dissolved via compulsory strike-off | ||
Voluntary liquidation. Notice of members return of final meeting | ||
Voluntary liquidation Statement of receipts and payments to 2024-03-05 | ||
LIQ03 | Voluntary liquidation Statement of receipts and payments to 2022-03-05 | |
LIQ03 | Voluntary liquidation Statement of receipts and payments to 2021-03-05 | |
AA | FULL ACCOUNTS MADE UP TO 31/03/20 | |
AD01 | REGISTERED OFFICE CHANGED ON 01/04/20 FROM Chirotech Technology Centre 410 Cambridge Science Park Milton Road Cambridge CB4 0PE | |
600 | Appointment of a voluntary liquidator | |
LIQ01 | Voluntary liquidation declaration of solvency | |
LRESSP | Resolutions passed:
| |
AP01 | DIRECTOR APPOINTED MR. SUMIT KUSHWAHA | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR SUBIR KOHLI | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/11/19, WITH NO UPDATES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CLEMENS JOHANNES TROCHE | |
AA | FULL ACCOUNTS MADE UP TO 31/03/19 | |
AP01 | DIRECTOR APPOINTED MR. CLEMENS JOHANNES TROCHE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DAVID ANDREW CHAPLIN | |
CS01 | CONFIRMATION STATEMENT MADE ON 03/12/18, WITH UPDATES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR GUNAPATHI VENKATESHWARA PRASAD | |
AP03 | Appointment of Mr. Sumit Kushwaha as company secretary on 2018-08-24 | |
TM02 | Termination of appointment of Pakala Chakrapani on 2018-08-24 | |
AA | FULL ACCOUNTS MADE UP TO 31/03/18 | |
CS01 | CONFIRMATION STATEMENT MADE ON 03/12/17, WITH UPDATES | |
AP03 | Appointment of Mr Pakala Chakrapani as company secretary on 2017-08-31 | |
TM02 | Termination of appointment of Abbas Bandali on 2017-08-31 | |
AA | FULL ACCOUNTS MADE UP TO 31/03/17 | |
AA | FULL ACCOUNTS MADE UP TO 31/03/16 | |
LATEST SOC | 19/12/16 STATEMENT OF CAPITAL;GBP 20778057.7 | |
CS01 | CONFIRMATION STATEMENT MADE ON 03/12/16, WITH UPDATES | |
CS01 | CONFIRMATION STATEMENT MADE ON 03/12/16, WITH UPDATES | |
LATEST SOC | 12/01/16 STATEMENT OF CAPITAL;GBP 20778057.7 | |
AR01 | 03/12/15 ANNUAL RETURN FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/03/15 | |
AP01 | DIRECTOR APPOINTED MR VENKATA NARSIMHAM MANNAM | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PARSURAM VENGANALLORE VENKITESWARAN | |
AA | FULL ACCOUNTS MADE UP TO 31/03/14 | |
LATEST SOC | 29/12/14 STATEMENT OF CAPITAL;GBP 20778057.7 | |
AR01 | 03/12/14 ANNUAL RETURN FULL LIST | |
AP01 | DIRECTOR APPOINTED MR SUBIR KOHLI | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR RAGHUNATHAN ANANTHANARAYANAN | |
LATEST SOC | 20/12/13 STATEMENT OF CAPITAL;GBP 20778057.7 | |
AR01 | 03/12/13 ANNUAL RETURN FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/03/13 | |
RES01 | ADOPT ARTICLES 19/09/13 | |
RES13 | SECTION 549 13/09/2013 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
SH08 | NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES | |
TM02 | APPOINTMENT TERMINATED, SECRETARY SRINIVAS DRONAMRAJU | |
AP03 | SECRETARY APPOINTED MR ABBAS BANDALI | |
AP01 | DIRECTOR APPOINTED MR DAVID ANDREW CHAPLIN | |
AP01 | DIRECTOR APPOINTED MR PARSURAM VENGANALLORE VENKITESWARAN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JONATHAN KILHAM | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR VISHWANATH VEMURI | |
AA | ACCOUNTS FOR 'MEDIUM' CO. MADE UP TO 31/03/12 | |
AR01 | 03/12/12 FULL LIST | |
AP03 | SECRETARY APPOINTED MR SRINIVAS DRONAMRAJU | |
TM02 | APPOINTMENT TERMINATED, SECRETARY SAMEER NATU | |
AP01 | DIRECTOR APPOINTED DR RAGHUNATHAN ANANTHANARAYANAN | |
AR01 | 03/12/11 FULL LIST | |
AD02 | SAIL ADDRESS CHANGED FROM: UNIT 162 CAMBRIDGE SCIENCE PARK MILTON ROAD CAMBRIDGE CAMBRIDGESHIRE CB4 4WE | |
AA | ACCOUNTS FOR 'MEDIUM' CO. MADE UP TO 31/03/11 | |
AD01 | REGISTERED OFFICE CHANGED ON 04/05/2011 FROM 410 CAMBRIDGE SCIENCE PARK MILTON ROAD CAMBRIDGE CB4 0PE ENGLAND | |
CH03 | SECRETARY'S CHANGE OF PARTICULARS / SAMEER NATU / 21/04/2011 | |
AD01 | REGISTERED OFFICE CHANGED ON 06/04/2011 FROM UNIT 162 CAMBRIDGE SCIENCE PARK MILTON ROAD CAMBRIDGE CAMBRIDGESHIRE CB4 4WE | |
AR01 | 03/12/10 FULL LIST | |
AA | ACCOUNTS FOR 'MEDIUM' CO. MADE UP TO 31/03/10 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ABHIJIT MUKHERJEE | |
AP01 | DIRECTOR APPOINTED VISHWANATH VEMURI | |
AP01 | DIRECTOR APPOINTED JONATHAN KILHAM | |
AA | ACCOUNTS FOR 'MEDIUM' CO. MADE UP TO 31/03/09 | |
AR01 | 03/12/09 FULL LIST | |
AD02 | SAIL ADDRESS CREATED | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / KALLAM SATISH REDDY / 01/10/2009 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / GUNAPATHI VENKATESHWARA PRASAD / 01/10/2009 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / ABHIJIT MUKHERJEE / 01/10/2009 | |
RES01 | ADOPT ARTICLES 29/09/2009 | |
363a | RETURN MADE UP TO 03/12/08; FULL LIST OF MEMBERS; AMEND | |
363a | RETURN MADE UP TO 03/12/08; FULL LIST OF MEMBERS | |
225 | CURREXT FROM 31/12/2008 TO 31/03/2009 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/07 | |
288a | DIRECTOR APPOINTED KALLAM SATISH REDDY | |
288a | DIRECTOR APPOINTED ABHIJIT MUKHERJEE | |
288a | DIRECTOR APPOINTED GUNUPATI VENKATESWARA PRASAD | |
288a | SECRETARY APPOINTED SAMEER SUDHAKAR NATU | |
288b | APPOINTMENT TERMINATED DIRECTOR KEITH WIGGINS | |
288b | APPOINTMENT TERMINATED DIRECTOR GEOFFREY FINKEMEYER | |
288b | APPOINTMENT TERMINATED SECRETARY IONA DANCE | |
287 | REGISTERED OFFICE CHANGED ON 03/06/2008 FROM DIAMOND HOUSE LOTUS PARK KINGSBURY CRESCENT STAINES MIDDLESEX TW18 3AG | |
RES04 | GBP NC 829897.8/10829897.8 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
123 | NC INC ALREADY ADJUSTED 21/12/05 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/06 | |
363a | RETURN MADE UP TO 03/12/07; FULL LIST OF MEMBERS | |
288c | DIRECTOR'S PARTICULARS CHANGED | |
288c | DIRECTOR'S PARTICULARS CHANGED | |
288c | SECRETARY'S PARTICULARS CHANGED | |
287 | REGISTERED OFFICE CHANGED ON 10/09/07 FROM: 2 HEATHROW BOULEVARD 284 BATH ROAD WEST DRAYTON MIDDLESEX UB7 0DQ | |
AA | FULL ACCOUNTS MADE UP TO 31/12/05 | |
363(288) | DIRECTOR'S PARTICULARS CHANGED | |
363s | RETURN MADE UP TO 03/12/06; FULL LIST OF MEMBERS | |
288c | DIRECTOR'S PARTICULARS CHANGED | |
288a | NEW DIRECTOR APPOINTED | |
288b | DIRECTOR RESIGNED | |
123 | NC INC ALREADY ADJUSTED 21/12/05 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RES04 | £ NC 829898/10778058 21/ |
Resolutions for Winding-up | 2020-03-18 |
Notices to Creditors | 2020-03-18 |
Appointment of Liquidators | 2020-03-18 |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max | |
MortgagesNumMortCharges | 1.49 | 9 |
MortgagesNumMortOutstanding | 0.56 | 9 |
MortgagesNumMortPartSatisfied | 0.00 | 0 |
MortgagesNumMortSatisfied | 0.93 | 9 |
This shows the max and average number of mortgages for companies with the same SIC code of 21100 - Manufacture of basic pharmaceutical products
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on CHIROTECH TECHNOLOGY LIMITED
The top companies supplying to UK government with the same SIC code (21100 - Manufacture of basic pharmaceutical products) as CHIROTECH TECHNOLOGY LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
![]() | 39269097 | Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s. | ||
![]() | 39269097 | Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s. | ||
![]() | 29 | |||
![]() | 29 | |||
![]() | 84818099 | Appliances for pipes, boiler shells, tanks, vats or the like (excl. pressure-reducing valves, valves for the control of pneumatic power transmission, check "non-return" valves, safety or relief valves, taps, cocks and valves for sinks, baths and similar fixtures, central heating radiator valves, valves for pneumatic tyres and inner-tubes, process control valves, globe valves, gate valves, ball and plug valves, butterfly valves and diaphragm valves) | ||
![]() | 84818099 | Appliances for pipes, boiler shells, tanks, vats or the like (excl. pressure-reducing valves, valves for the control of pneumatic power transmission, check "non-return" valves, safety or relief valves, taps, cocks and valves for sinks, baths and similar fixtures, central heating radiator valves, valves for pneumatic tyres and inner-tubes, process control valves, globe valves, gate valves, ball and plug valves, butterfly valves and diaphragm valves) | ||
![]() | 28439090 | Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold) | ||
![]() | 28439090 | Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29151300 | Esters of formic acid | ||
![]() | 29151300 | Esters of formic acid | ||
![]() | 29241900 | Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO]) | ||
![]() | 29241900 | Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO]) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29224985 | Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine) | ||
![]() | 29224985 | Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine) | ||
![]() | 29339980 | Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl | ||
![]() | 29339980 | Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl | ||
![]() | 29241900 | Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO]) | ||
![]() | 29241900 | Acyclic amides, incl. acyclic carbamates, and their derivatives, and salts thereof (excl. meprobamate [INN], fluoroacetamide [ISO], monocrotophos [ISO] and phosphamidon [ISO]) | ||
![]() | 29224985 | Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine) | ||
![]() | 29224985 | Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine) | ||
![]() | 29319000 | |||
![]() | 30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | ||
![]() | 29 | |||
![]() | 29130000 | Halogenated, sulphonated, nitrated or nitrosated derivatives of cyclic polymers of aldehydes or paraformaldehyde | ||
![]() | 29 | |||
![]() | 29130000 | Halogenated, sulphonated, nitrated or nitrosated derivatives of cyclic polymers of aldehydes or paraformaldehyde | ||
![]() | 29130000 | Halogenated, sulphonated, nitrated or nitrosated derivatives of cyclic polymers of aldehydes or paraformaldehyde | ||
![]() | 29130000 | Halogenated, sulphonated, nitrated or nitrosated derivatives of cyclic polymers of aldehydes or paraformaldehyde | ||
![]() | 29319080 | |||
![]() | 30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | ||
![]() | 30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | ||
![]() | 28439090 | Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold) | ||
![]() | 28439090 | Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold) | ||
![]() | 29 | |||
![]() | 29319080 | |||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29130000 | Halogenated, sulphonated, nitrated or nitrosated derivatives of cyclic polymers of aldehydes or paraformaldehyde | ||
![]() | 28439090 | Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold) | ||
![]() | 30042000 | Medicaments containing antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof) | ||
![]() | 29319080 | |||
![]() | 84219100 | Parts of centrifuges, incl. centrifugal dryers, n.e.s. | ||
![]() | 90279010 | Microtomes | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | ||
![]() | 30042000 | Medicaments containing antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof) | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 30042000 | Medicaments containing antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof) | ||
![]() | 30042000 | Medicaments containing antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof) | ||
![]() | 29329900 | Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury) | ||
![]() | 29329900 | Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury) | ||
![]() | 90279010 | Microtomes | ||
![]() | 90279010 | Microtomes | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 90279080 | Parts and accessories of microtomes or of gas or smoke analysis apparatus, n.e.s. | ||
![]() | 90279080 | Parts and accessories of microtomes or of gas or smoke analysis apparatus, n.e.s. | ||
![]() | 28439090 | Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold) | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 37079090 | Preparation of chemicals for photographic uses, incl. unmixed products put up in measured portions or put up for retail sale in a form ready for use (excl. varnishes, glues, adhesives and similar preparations, sensitising emulsions, developers and fixers and salts and precious-metal compounds etc. of heading 2843 to 2846) | ||
![]() | 28439090 | Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold) | ||
![]() | 30045000 | Medicaments containing provitamins, vitamins, incl. natural concentrates and derivatives thereof used primarily as vitamins, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale | ||
![]() | 29333999 | Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami | ||
![]() | 90272000 | Chromatographs and electrophoresis instruments | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 84021990 | Vapour generating boilers, incl. hybrid boilers (excl. watertube boilers, firetube boilers and central heating hot water boilers capable also of producing low pressure steam) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29319090 | Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro | ||
![]() | 29122900 | Cyclic aldehydes, without other oxygen function (excl. benzaldehyde) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 34042000 | Poly"oxyethylene" [polyethylene glycol] waxes | ||
![]() | 84212100 | Machinery and apparatus for filtering or purifying water | ||
![]() | 90189084 | Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s. | ||
![]() | 29319090 | Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro | ||
![]() | 30049000 | Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins | ||
![]() | 34042000 | Poly"oxyethylene" [polyethylene glycol] waxes | ||
![]() | 32 | |||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29349990 | Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 29 | |||
![]() | 29094980 | Cyclic ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. 2-(2-Chloroethoxy)ethanol) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29094980 | Cyclic ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. 2-(2-Chloroethoxy)ethanol) | ||
![]() | 29162000 | Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. inorganic or organic compounds of mercury) | ||
![]() | 35069900 | Glues, prepared, and other prepared adhesives, n.e.s. | ||
![]() | 85169000 | Parts of electric water heaters, immersion heaters, space-heating apparatus and soil-heating apparatus, hairdressing apparatus and hand dryers, electro-thermic appliances of a kind used for domestic purposes and electric heating resistors, n.e.s. | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29337900 | Lactams (excl. 6-hexanelactam "epsilon-caprolactam", clobazam "INN", methyprylon "INN", and inorganic or organic compounds of mercury) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 85234045 | |||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29094980 | Cyclic ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. 2-(2-Chloroethoxy)ethanol) | ||
![]() | 29161200 | Esters of acrylic acid | ||
![]() | 35079030 | Lipoprotein lipase and aspergillus alkaline protease | ||
![]() | 29094980 | Cyclic ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. 2-(2-Chloroethoxy)ethanol) | ||
![]() | 29161200 | Esters of acrylic acid | ||
![]() | 29222900 | Amino-naphthols and other amino-phenols, their ethers and esters; salts thereof (excl. those containing > one kind of oxygen function; aminohydroxynaphthalenesulphonic acids and their salts) | ||
![]() | 29375000 | Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues, used primarily as hormones | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29094980 | Cyclic ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. 2-(2-Chloroethoxy)ethanol) | ||
![]() | 29161200 | Esters of acrylic acid | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29349960 | Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29094980 | Cyclic ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. 2-(2-Chloroethoxy)ethanol) | ||
![]() | 29161200 | Esters of acrylic acid | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29 | |||
![]() | 29141990 | Acyclic ketones without other oxygen function (excl. acetone, butanone "methyl ethyl ketone", 4-Methylpentan-2-one "Methyl isobutyl ketone" and 5-methylhexan-2-one) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 29122900 | Cyclic aldehydes, without other oxygen function (excl. benzaldehyde) | ||
![]() | 29162000 | Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. inorganic or organic compounds of mercury) | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 84733080 | Parts and accessories of automatic data-processing machines or for other machines of heading 8471, n.e.s. (excl. electronic assemblies) | ||
![]() | 29122900 | Cyclic aldehydes, without other oxygen function (excl. benzaldehyde) | ||
![]() | 29162000 | Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. inorganic or organic compounds of mercury) | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 29221985 | Amino-alcohols, their ethers and esters; salts thereof (other than those containing > one kind of oxygen function and excl. monoethanolamine, diethanolamine, triethanolamine, dextropropoxyphene "INN" and their salts, and N-ethyldiethanolamine and 2,2'-methyliminodiethanol "N-methyldiethanolamine" and 2-(N,N-Diisopropylamino)ethanol) | ||
![]() | 35079090 | Enzymes and prepared enzymes, n.e.s. (excl. rennet and concentrates thereof, lipoprotein lipase and Aspergillus alkaline protease) | ||
![]() | 39072011 | Polyethylene glycols, in primary forms | ||
![]() | 29 | |||
![]() | 29171990 | Acyclic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. oxalic acid, its salts and esters, adipic acid, its salts and esters, azelaic acid, sebacic acid, their salts and esters, malonic acid, its salts and esters, maleic anhydride, and inorganic or organic compounds of mercury) | ||
![]() | 38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Initiating party | Event Type | Resolutions for Winding-up | |
---|---|---|---|
Defending party | CHIROTECH TECHNOLOGY LIMITED | Event Date | 2020-03-06 |
Notice is hereby given that the following resolutions were passed on 6 March 2020 , as a special resolution and an ordinary resolution respectively: "That the Company be wound up voluntarily and that Sarah Louise Burge (IP No. 9698 ) of Kingsbridge Corporate Solutions Limited , 1st Floor, Lowgate House, Lowgate, Hull HU1 1EL be appointed as Liquidator for the purposes of such voluntary winding up." For further details contact: Sarah Louise Burge, Tel: 01482 337500 . Ag QG121987 | |||
Initiating party | Event Type | Notices to Creditors | |
Defending party | CHIROTECH TECHNOLOGY LIMITED | Event Date | 2020-03-06 |
Notice is hereby given that Creditors of the Company are required, on or before 9 April 2020 , to prove their debts by delivering their proofs (in the format specified in Rule 14.4 of the Insolvency (England and Wales) Rules 2016) to the Liquidator at Kingsbridge Corporate Solutions,1st Floor, Lowgate House, Lowgate, Hull, HU1 1EL. If so required by notice in writing from the Liquidator, creditors must produce any document or other evidence which the Liquidator considers is necessary to substantiate the whole or any part of a claim. Note: The Directors of the Company have made a declaration of solvency and it is expected that all creditors will be paid in full. Date of Appointment: 6 March 2020 Office Holder Details: Sarah Louise Burge (IP No. 9698 ) of Kingsbridge Corporate Solutions Limited , 1st Floor, Lowgate House, Lowgate, Hull HU1 1EL For further details contact: Sarah Louise Burge, Tel: 01482 337500 . Ag QG121987 | |||
Initiating party | Event Type | Appointment of Liquidators | |
Defending party | CHIROTECH TECHNOLOGY LIMITED | Event Date | 2020-03-06 |
Sarah Louise Burge (IP No. 9698 ) of Kingsbridge Corporate Solutions Limited , 1st Floor, Lowgate House, Lowgate, Hull HU1 1EL : Ag QG121987 | |||
Category | Award/Grant | |
---|---|---|
Utilisation of Electrodialysis membranes for the recovery of amino acids from enzymatic reaction mixtures-(EDAM). : Feasibility Study | 2014-03-01 | £ 50,852 |
Manufacture of chiral amines using catalytic and flow processing methods : Collaborative Research and Development | 2013-02-01 | £ 10,064 |
Production of Pharmaceutical Intermediates using fermentation of genetically engineered microorganisms : Collaborative Research and Development | 2013-01-01 | £ 322,520 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |